Spark Therapeutics enters into gene therapy collaboration targeting Huntington's disease

The agreement includes upfront, research and development, and sales milestone payments and license fees valued at up to about $190 million.

Source: bizjournals.com Health Care:Biotechnology headlines - September 7, 2021 Category: Biotechnology Authors: John George Source Type: news